BriaCell Therapeutics Corp (BCTX)
1.48
+0.09
(+6.47%)
USD |
NASDAQ |
May 20, 14:23
BriaCell Therapeutics 1 Year Total Returns (Daily): -77.47% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 17, 2024 | -77.47% |
| May 16, 2024 | -78.13% |
| May 15, 2024 | -75.19% |
| May 14, 2024 | -67.54% |
| May 13, 2024 | -65.69% |
| May 10, 2024 | -68.38% |
| May 09, 2024 | -69.00% |
| May 08, 2024 | -68.98% |
| May 07, 2024 | -68.71% |
| May 06, 2024 | -67.57% |
| May 03, 2024 | -67.99% |
| May 02, 2024 | -67.72% |
| May 01, 2024 | -70.28% |
| April 30, 2024 | -70.83% |
| April 29, 2024 | -70.97% |
| April 26, 2024 | -68.96% |
| April 25, 2024 | -67.58% |
| April 24, 2024 | -69.33% |
| April 23, 2024 | -68.44% |
| April 22, 2024 | -70.07% |
| April 19, 2024 | -71.94% |
| April 18, 2024 | -70.34% |
| April 17, 2024 | -71.50% |
| April 16, 2024 | -68.33% |
| April 15, 2024 | -67.78% |
| Date | Value |
|---|---|
| April 12, 2024 | -65.13% |
| April 11, 2024 | -61.99% |
| April 10, 2024 | -62.60% |
| April 09, 2024 | -59.57% |
| April 08, 2024 | -58.44% |
| April 05, 2024 | -62.06% |
| April 04, 2024 | -60.48% |
| April 03, 2024 | -60.06% |
| April 02, 2024 | -63.09% |
| April 01, 2024 | -62.01% |
| March 28, 2024 | -58.67% |
| March 27, 2024 | -62.76% |
| March 26, 2024 | -63.40% |
| March 25, 2024 | -58.93% |
| March 22, 2024 | -62.67% |
| March 21, 2024 | -66.37% |
| March 20, 2024 | -67.95% |
| March 19, 2024 | -61.40% |
| March 18, 2024 | -58.69% |
| March 15, 2024 | -57.86% |
| March 14, 2024 | -57.43% |
| March 13, 2024 | -56.49% |
| March 12, 2024 | -51.47% |
| March 11, 2024 | -50.98% |
| March 08, 2024 | -57.72% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-80.54%
Minimum
Apr 02 2020
189.1%
Maximum
Mar 28 2022
-14.10%
Average
-29.10%
Median
Jan 13 2020
1 Year Total Returns (Daily) Benchmarks
| CeCors Inc | -45.70% |
| Venus Concept Inc | -75.65% |
| Acasti Pharma Inc | -10.35% |
| Aurinia Pharmaceuticals Inc | -46.22% |
| Edesa Biotech Inc | -30.85% |